About
Contact & Profiles
A5033365467
Research Areas
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Protein Kinase Regulation and GTPase Signaling
- Systemic Lupus Erythematosus Research
- Diabetes and associated disorders
- Immunotherapy and Immune Responses
- Colorectal and Anal Carcinomas
- Cancer Cells and Metastasis
- PARP inhibition in cancer therapy
- Cancer therapeutics and mechanisms
- Bladder and Urothelial Cancer Treatments
- Gastric Cancer Management and Outcomes
- Melanoma and MAPK Pathways
- Colorectal Cancer Screening and Detection
- Renal cell carcinoma treatment
- DNA Repair Mechanisms
- Liver Diseases and Immunity
- PI3K/AKT/mTOR signaling in cancer
- Genetic factors in colorectal cancer
- Helicobacter pylori-related gastroenterology studies
Saint Joseph University
2021-2024
Gastric cancer (GC) ranks as the fifth most prevalent and fourth deadliest worldwide. In Middle East North Africa (MENA) region, GC represents about 4.8% of cases with more than 35,000 new in 2020. To strengthen improve management this a group MENA experts field developed first consensus recommendations for advanced GC. A total 28 statements were drafted, discussed voted on, using modified Delphi process, during virtual meeting. The addressed areas epidemiology, biomarkers treatment.
10.2217/fon-2023-0219
article
EN
Future Oncology
2023-07-01
Coming Soon ...